Generation of bioengineered liver grafts densely recellularized using human liver organoids
Cell Transplantation · 2026
DOI: 10.1177/09636897261474318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Transplantation, 2026. Verfasst von Keita Sonoda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Organoids, Liver, Liver Transplantation, Tissue Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Bioengineered livers using decellularized extracellular matrix (ECM) scaffolds hold promise for transplantation therapies. However, conventional recellularization methods involving cell injection via blood vessels encounter challenges in recapitulating the complexity of hepatic tissues, including high cellularity, differentiation hierarchy, and cellular heterogeneity. Here, we developed a methodology termed “combined single-cell and organoid (CSO) injection.” We injected human liver organoids (HLOs) and dispersed organoid cells via direct puncture and vascular injection into a decellularized porcine ECM scaffold, respectively. This process facilitated the construction of densely populated and self-organized liver-like tissues (CSO Livers) that formed cell-cell/cell-ECM interactions. The tissues displayed hepatic characteristics, including ALBUMIN secretion, robust expression of liver-associated genes, and cellular heterogeneity comprising hepatocytes, cholangiocytes, as well as stellate-like and endothelial cells. Furthermore, we demonstrated that CSO-Livers functioned as grafts in immunodeficient mice and in a microminipig model of liver fibrosis through transplantation via vascular anastomosis. These findings indicate the applicability of the combined single-cell and organoid (CSO) injection method for generating bioengineered liver grafts using HLOs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
- Department of Proteomics, Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Tokyo, Japan.
- Division of Regenerative Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Keita Sonoda, Kotaro Nishi
Zitieren
APA
Sonoda, K., Yagi, H., Nagata, S., Tsuchida, T., Nishi, K., Morisaku, T., Ohtomo, M., Adachi, S., Okamoto, S., Kamishibahara, Y., Kuse, Y., Taniguchi, H., & Kitagawa, Y. (2026). Generation of bioengineered liver grafts densely recellularized using human liver organoids. Cell Transplantation. https://doi.org/10.1177/09636897261474318
Vancouver
Sonoda K, Yagi H, Nagata S, Tsuchida T, Nishi K, Morisaku T, et al. Generation of bioengineered liver grafts densely recellularized using human liver organoids. Cell Transplantation. 2026. doi:10.1177/09636897261474318
BibTeX
@article{Sonoda2026,
author = {Sonoda, Keita and Yagi, Hiroshi and Nagata, Shogo and Tsuchida, Tomonori and Nishi, Kotaro and Morisaku, Toshinori and Ohtomo, Mana and Adachi, Shungo and Okamoto, Satoshi and Kamishibahara, Yu and Kuse, Yoshiki and Taniguchi, Hideki and Kitagawa, Yuko},
title = {Generation of bioengineered liver grafts densely recellularized using human liver organoids},
journal = {Cell Transplantation},
year = {2026},
doi = {10.1177/09636897261474318}
}
EUVIMED